Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
GlobalData on MSN1d
Regeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
Gov. Hohcul announced part of Saint Rose campus will be turned into a workforce development hub as part of the ON RAMP initiative ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
Vivek Malik, a student from the Hackley School in Tarrytown, has been named a finalist in the prestigious Regeneron Science Talent Search. Malik will now compete against 39 other high school ...
Hosted on MSN18d
Tarrytown teen in running for share of $2 million in Regeneron Science Talent SearchMalek will now compete against 39 other high school seniors from 16 states for a share of nearly $2 million in awards. Costco won't join DEI backlash. Why shareholders rejected anti-'woke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback